| Issue Date | Title | Author(s) |
| 2021 | Assessment of the nephroprotective properties of the erythropoietin mimetic peptide and infliximab in kidney ischemia-reperfusion injury in rat | Netrebenko, A. S.; Gureev, V. V.; Pokrovskii, M. V.; Gureeva, A. V.; Tsuverkalova, Y. M.; Rozhkov, I. S. |
| 2020 | Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia | Lokteva, T. I.; Rozhkov, I. S.; Gureev, V. V.; Gureeva, A. V.; Zatolokina, M. A. |
| 2020 | Endothelial protective properties of short-chain peptides that mimic α-helix B of erythropoietin in experimental preeclampsia | Golubev, I. V.; Gureev, V. V.; Korokin, M. V.; Gureeva, A. V.; Polyanskaya, A. V.; Pokrovskii, M. V.; Lazareva, G. A.; Bystrova, N. A. |
| 2019 | Influence of silver-ion-containing pharmacotherapeutic system for repair of anterior abdominal wall on connective tissue formation in experiment | Mishina, E. S.; Zatolokina, M. A.; Gureeva, A. V.; Gureev, V. V.; Elagina, K. A. |
| 2022 | Study of the effect of acetylsalicylic acid and a selective arginase II inhibitor KUD 975 on the correction of hemostatic disorders in experimental preeclampsia | Gureeva, A. V.; Severinova, O. V.; Gureev, V. V.; Kochkarova, I. S.; Avdeyeva, E. V. |
| 2019 | Study of the effect of selective inhibitor of arginase II KUD 975 and of low doses of acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia | Severinova, O. V.; Gureev, V. V.; Zhilinkova, L. A.; Lazareva, G. A.; Gureeva, A. V. |
| 2020 | The effectiveness of trimetazidine and its combination with methyldopa in experimental preeclampsia | Antsiferova, O. E.; Gureev, V. V.; Gureeva, A. V.; Zatolokina, M. A.; Rozhkov, I. S.; Polyanskaya, A. V. |
